Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in canada

Sexually Transmitted Diseases

Volumn 36, Issue 6, 2009, Pages 380-386

  Kliewer, Erich V ^a,b,c   Demers, Alain A ^a,b   Elliott, Lawrence ^b,c   Lotocki, Robert ^b,d   Butler, James R G ^e   Brisson, Marc ^f  

^a Cancer Care Manitoba ^*  (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d CANCERCARE MANITOBA   (Canada)

^e AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^f UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHILD; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; TREND STUDY; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANUS DISEASES; CANADA; CHILD; CHILD, PRESCHOOL; CONDYLOMATA ACUMINATA; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; INCIDENCE; INFANT; MALE; MANITOBA; MEDICAL RECORDS; MIDDLE AGED; PREVALENCE;

EID: 67049146402     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318198de8c     Document Type: Article

References (57)

1. Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995; 33:2058-2063.
2. Koshiol JE, Laurent SA, Pimenta JM. Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis 2004; 31:748-752.
3. Kjaer SK, Tran TN, Sparen P, et al. The burden of genital warts: A study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007; 196:1447-1454.
4. Marra F, Ogilvie G, Colley L, et al. Epidemiology and costs associated with genital warts in Canada. Sex Trans Infect. In press. Available at: http://sti.bmj.com/cgi/rapidpdf/sti.2008.030999vl.
5. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Am Social Health Association Panel. Sex Transm Dis 1999; 26(suppl):S2-S7.
6. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003; 36:1397-1403.
7. Sonnex C, Lacey CJ. The treatment of human papillomavirus lesions of the lower genital tract. Best Pract Res Clin Obstet Gynaecol 2001; 15:801-816.
8. Chuang TY, Perry HO, Kurland LT, et al. Condyloma acumina-tum in Rochester, Minnesota, 1950-1978. I. Epidemiology and clinical features Arch Dermatol 1984; 120:469-475.
9. Becker TM, Stone KM, Alexander ER. Genital human papillomavirus infection. A growing concern. Obstet Gynecol North Am 1987; 14:389-396.
10. United Kingdom. Health Protection Agency. STIs Slidesets-HIV STI 2006 Other STIs. 2008. Available at: www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/ 1204619478607. Accessed August 12, 2008.
11. Schofield MJ, Minichiello V, Mishra GD, et al. Sexually transmitted infections and use of sexual health services among young Australian women: Women's Health Australia study. Int J STD AIDS 2000; 11:313-323.
12. Kjaer SK, Lynge E. Incidence, prevalence and time trends of genital HPV infection determined by clinical examination and cytology. IARC Sci Publ 1989; 94:113-124.
13. Simms I, Fairley CK. Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997; 73:365-367.
14. Simms I, Fleming DM, Lowndes CM, et al. Surveillance of sexually transmitted diseases in general practice: A description of trends in the Royal College of General Practitioners Weekly Returns Service between 1994 and 2001. Int J STD AIDS 2006; 17:693-698.
15. Insinga RP, Dasbach EJ. The clinical incidence of Condyloma acuminata in a set of private US health plans. In: Program and Abstracts of the Clinical Workshop and 20th International Papillomavirus Conference. 231, 2002; Paris, France.
16. Singhal PK, Schabert V, Insinga RP, et al. The incidence and healthcare cost of genital warts in a commercially insured population in the United States. In: Abstract Book of the 24th International Papillomavirus Conference and Clinical Workshop. 200,2007; Beijing, China.
17. Cassell JA, Mercer CH, Sutcliffe L, et al. Trends in sexually transmitted infections in general practice 1990 to 2000: Population based study using data from the UK general practice research database. BMJ 2006; 332:332-334.
18. Monsonego J, Breugelmans JG, Bouee S, et al. [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France.] Gynecol Obstet Fertil 2007; 35:107-113.
19. Persson G, Andersson K, Krantz I. Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture. Acta Obstet Gynecol Scand 1996; 75:287-290.
20. Conway EL, Stein AN, Britt H, et al. Genital warts and associated health care in general practice in Australia. In: Abstract Book of the 24th International Papillomavirus Conference and Clinical Workshop. 198, 2007; Beijing, China.
21. Sellors JW, Mahony JB, Kaczorowski J, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000; 163:503-508.
22. Meisels A, Morin C. Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol 1981; 12(pt 2):S111-S123.
23. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8.
24. Grulich AE, de Visser RO, Smith AM, et al. Sex in Australia: Sexually transmissible infection and blood-borne virus history in a representative sample of adults. Aust N Z J Public Health 2003; 27:234-241.
25. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977; 78:1-30.
26. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163.
27. Turpin J, Liaw KL, Ovemess T, et al. The incidence and prevalence of genital warts and HPV infection in young sexually active Nor- wegian women, In: Program and Abstracts of the Clinical Workshop and 20th International Papillomavirus Conference. 282, 2002; Paris, France.
28. Wen LM, Estcourt CS, Simpson JM, et al. Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect 1999; 75:312-316.
29. Van Den Eeden SK, Habel LA, Sherman KJ, et al. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis 1998; 25:278-284.
30. Habel LA, Van Den Eeden SK, Sherman KJ, et al. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis 1998; 25:285-292.
31. Munk C, Svare El, Poll P, et al. History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history. Sex Transm Dis 1997; 24:567-572.
32. Daling JR, Sherman KJ, Weiss NS. Risk factors for condyloma acuminatum in women. Sex Transm Dis 1986; 13:16-18.
33. Public Health Agency of Canada. 2004 Canadian sexually transmitted infections surveillance report. Can Commun Dis Rep 2007; 33(suppl l):l-69.
34. Beltrami JF, Shouse RL, Blake PA. Trends in infectious diseases and the male to female ratio: possible clues to changes in behavior among men who have sex with men. AIDS Educ Prev 2005; 17(suppl B):49-59.
35. Tjepkema M. Health care use among gay, lesbian and bisexual Canadians. Health Rep 2008; 19:53-64.
36. Lampinen TM, Chan K, Craib KJP, et al. Trends in condom use and HIV-1 seroincidence in a cohort of young men who have sex with men (MSM) in Vancouver, 1997-2002. Can J Infect Dis Med Microbiol 2003; 14(suppl SA):41A.
37. George C, Alary M, Otis J, et al. Nonnegligible increasing temporal trends in unprotected anal intercourse among men who have sexual relations with other men in Montreal. J Acquir Immun Defic Syndr 2006; 41:365-370.
38. de Sanjosfi S, Diaz M, Castellsague X, et al. Worldwide preva-lence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 2007; 7:453-459.
39. Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 2008; 43(suppl 1):S5-S25, S25 e1-e41.
40. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-819.
41. Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008; 123:1864-1870.
42. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: Human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States Cancer Epidemiol Biomarkers Prev 2008; 17:2036-2043.
43. Giuliano AR, Lu B, Nielson CM, et al. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 2008; 198:827-835.
44. Nyitray A, Nielson CM, Harris RB, et al. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis 2008; 197:1676-1684.
45. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men: The EXPLORE study. J Natl Cancer Inst 2005; 97:896-905.
46. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-specific prevalence of anal human papillomavirus infection in HlV-neg-ative sexually active men who have sex with men: The EXPLORE study. J Infect Dis 2004; 190:2070-2076.
47. Roos LL, Gupta S, Soodeen RA, et al. Data quality in an information-rich environment: Canada as an example. Can J Aging 2005; 24(suppl 1):153-170.
48. O'Malley KJ, Cook KF, Price MD, et al. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005; 40(pt 2):1620-1639.
49. Surjdn G. Questions on validity of International Classification of Diseases-coded diagnoses. Int J Med Inform 1999; 54:77-95.
50. Beutner KR, Reitano MV, Richwald GA, et al. External genital warts: report of the Am Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts. Clin Infect Dis 1998; 27:796-806.
51. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(suppl 1):S1-S15.
52. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 2002; 186:462-469.
53. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12:485-490.
54. Wiley DJ, Grosser S, Qi K, et al. Validity of self-reporting of episodes of external genital warts. Clin Infect Dis 2002; 35:39-45.
55. Garland S, Ung L, Conway EL, et al. The Australian Women's Health Survey: assessing the psychosocial burden of HPV related illness and preventative interventions. In: Abstract Book of the 24th International Papillomavirus Conference and Clinical Workshop. 199, 2007; Beijing, China.
56. Woodhall S, Ramsey T, Cai C, et al. Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008; 84:161-166.
57. Senecal M, Maunsell E, Brisson M, et al. Quality of life lost associated with external genital warts: Preliminary baseline analyses from a prospective cohort study. In: Abstract Book of the 24th International Papillomavirus Conference and Clinical Workshop. 194, 2007; Beijing, China.